Stuart Genschaw, MBA, discusses how his practice approaches cancer immunotherapy (CIT) management and the potential future pathways of care.
Stuart Genschaw, MBA
Advertisement
Articles by Stuart Genschaw, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Former USAID Health Chief Says Aid Cuts Are Costing Children's Lives
2
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
3
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
4
It’s the Best of Times and Worst of Times for Cancer Care in Tampa
5